Skip to main content

PAINWeek 2023 Main banner

Icon Legend

This session is not in your agenda.

This session is in your agenda. Click to remove it

Back

Linda Pestano, PhD

Chief Development Officer
Ensysce Biosciences
La Jolla, California

Disclosure information not submitted.

Presentation(s):

Intranasal and Oral Human Abuse Potential (HAP) Studies with PF614: A Novel Trypsin Activated Abuse Protected (TAAP) Extended-Release Oxycodone Prodrug
POSTER ABSTRACT
PF614-MPAR: A Novel Trypsin Activated Abuse Protected (TAAP) Extended-Release Oxycodone Prodrug with Overdose Protection
POSTER ABSTRACT